​
​

ClearPoint Neuro (CLPT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

ClearPoint Neuro Revenue Highlights

Latest Revenue (Y)

$23.95M

Latest Revenue (Q)

$8.12M

Main Segment (Y)

Biologics and Drug Delivery Revenue

ClearPoint Neuro Revenue by Period

ClearPoint Neuro Revenue by Year

DateRevenueChange
2023-12-31$23.95M16.56%
2022-12-31$20.55M26.09%
2021-12-31$16.30M27.05%
2020-12-31$12.83M14.37%
2019-12-31$11.22M52.54%
2018-12-31$7.35M-0.36%
2017-12-31$7.38M28.35%
2016-12-31$5.75M25.15%
2015-12-31$4.59M27.46%
2014-12-31$3.60M-8.30%
2013-12-31$3.93M-22.29%
2012-12-31$5.06M32.48%
2011-12-31$3.82M43.03%
2010-12-31$2.67M-

ClearPoint Neuro generated $23.95M in revenue during NA 2023, up 16.56% compared to the previous quarter, and up 325.77% compared to the same period a year ago.

ClearPoint Neuro Revenue by Quarter

DateRevenueChange
2024-09-30$8.12M3.36%
2024-06-30$7.86M2.87%
2024-03-31$7.64M12.17%
2023-12-31$6.81M18.19%
2023-09-30$5.76M-3.16%
2023-06-30$5.95M9.52%
2023-03-31$5.43M5.01%
2022-12-31$5.17M0.54%
2022-09-30$5.15M-1.04%
2022-06-30$5.20M3.36%
2022-03-31$5.03M17.49%
2021-12-31$4.28M-6.38%
2021-09-30$4.57M34.02%
2021-06-30$3.41M-15.31%
2021-03-31$4.03M8.45%
2020-12-31$3.72M5.59%
2020-09-30$3.52M42.03%
2020-06-30$2.48M-20.47%
2020-03-31$3.12M-2.96%
2019-12-31$3.21M9.67%
2019-09-30$2.93M12.32%
2019-06-30$2.61M5.41%
2019-03-31$2.47M8.61%
2018-12-31$2.28M25.98%
2018-09-30$1.81M9.76%
2018-06-30$1.65M1.41%
2018-03-31$1.62M-3.34%
2017-12-31$1.68M-2.20%
2017-09-30$1.72M-13.10%
2017-06-30$1.98M-1.55%
2017-03-31$2.01M22.75%
2016-12-31$1.64M1.16%
2016-09-30$1.62M46.42%
2016-06-30$1.10M-20.82%
2016-03-31$1.39M-7.77%
2015-12-31$1.51M21.28%
2015-09-30$1.25M50.95%
2015-06-30$825.74K-18.28%
2015-03-31$1.01M5.27%
2014-12-31$959.84K51.58%
2014-09-30$633.20K-46.74%
2014-06-30$1.19M44.54%
2014-03-31$822.53K-30.08%
2013-12-31$1.18M26.84%
2013-09-30$927.46K64.88%
2013-06-30$562.49K-55.51%
2013-03-31$1.26M-32.13%
2012-12-31$1.86M64.57%
2012-09-30$1.13M4.44%
2012-06-30$1.08M10.59%
2012-03-31$980.00K-15.82%
2011-12-31$1.16M0.80%
2011-09-30$1.15M59.76%
2011-06-30$722.89K-

ClearPoint Neuro generated $8.12M in revenue during Q3 2024, up 3.36% compared to the previous quarter, and up 136.50% compared to the same period a year ago.

ClearPoint Neuro Revenue Breakdown

ClearPoint Neuro Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Functional Neurosurgery Navigation and Therapy - Disposable Products$7.59M$7.59M$7.70M--
Capital Equipment and Software Revenue$1.83M$2.31M$1.43M$1.49M-
Capital Equipment and Software - Systems and Software Products$860.00K$1.51M$864.00K--
Capital Equipment and Software - Services$973.00K$795.00K$569.00K--
Biologics and Drug Delivery Revenue$13.60M$9.12M$6.79M$5.04M-
Biologics and Drug Delivery - Disposable Products$2.15M$3.69M$3.35M--
Functional Neurosurgery Navigation and Therapy$8.52M$9.12M$8.07M--
Functional Neurosurgery Navigation and Therapy - Services$931.00K$1.54M$375.00K--
Biologics and Drug Delivery - Services--$3.44M--
Capital Equipment-Related Service Revenue----$228.00K
Remaining Performance Obligations Capital Equipment-Related Service Revenue----$1.10M

ClearPoint Neuro's latest annual revenue breakdown by segment (product or service), as of Dec 23: Biologics and Drug Delivery Revenue (37.30%), Functional Neurosurgery Navigation and Therapy (23.37%), Functional Neurosurgery Navigation and Therapy - Disposable Products (20.81%), Biologics and Drug Delivery - Disposable Products (5.91%), Capital Equipment and Software Revenue (5.03%), Capital Equipment and Software - Services (2.67%), Functional Neurosurgery Navigation and Therapy - Services (2.55%), and Capital Equipment and Software - Systems and Software Products (2.36%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Mar 23Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Biologics And Drug Delivery$4.43M$4.31M$3.49M$3.37M$2.68M$2.25M$2.41M$2.15M$72.50K$244.95K----------
Capital Equipment And Software$831.00K$1.41M$357.00K$381.00K$396.00K$480.00K$619.00K$639.00K------------
Capital Equipment And Software - Systems and Software Products$552.00K$1.16M$81.00K$173.00K$178.00K$287.00K$434.00K$450.00K------------
Capital Equipment And Software - Services$279.00K$250.00K$276.00K$208.00K$218.00K$193.00K$185.00K$189.00K------------
Biologics And Drug Delivery - Disposable Products$2.06M$553.00K$455.00K$346.00K$594.00K$798.00K$1.23M$850.00K------------
Functional Neurosurgery Navigation and Therapy - Disposable Products-$1.93M$2.04M$1.87M$1.82M$1.86M$2.04M$1.80M$1.86M-----------
Functional Neurosurgery Navigation and Therapy-$1.93M$2.04M$1.92M$2.20M$2.36M$2.42M$2.17M$2.24M$2.14M----------
Functional Neurosurgery Navigation and Therapy - Services--$1.00K$44.00K$383.00K$503.00K$375.00K$375.00K$375.00K-----------
Biologics And Drug Delivery - Services------$1.45M$1.18M$1.30M-----------
Biologics and Drug Delivery - Disposable Products---------$852.00K----------
Biologics and Drug Delivery - Services---------$837.00K----------
Biologics and Drug Delivery Revenue---------$1.69M$1.66M---------
Capital Equipment and Software - Services---------$170.00K----------
Capital Equipment and Software - Systems and Software Products---------$284.00K----------
Capital Equipment and Software Revenue---------$454.00K$453.00K---------
Remaining Performance Obligations Capital Equipment-Related Service Revenue----------$800.00K-$-320.00K$992.00K------
Capital Equipment Related Service Revenue----------$100.00K$90.00K--------
Capital Equipment-Related Service Revenue-------------$217.00K$89.00K$121.00K----
Capital Equipment and Software Revenue Subtotal--------------$204.56K-----
Biologics and Drug Delivery Revenue Subtotal--------------$1.47M-----
Therapy Revenue Subtotal--------------$103.80K-----
Product Revenue-----------------$2.52M--
Service and Other Revenues-----------------$686.77K$333.04K$412.20K
Capital Equipment------------------$184.82K$241.29K
Functional Neurology------------------$1.85M$1.69M
Product Revenues------------------$2.59M$2.19M
Therapy1Member------------------$50.00K-
Therapy------------------$64.09K$17.83K
Biologics and Drug Delivery------------------$491.26K-
Capital Equipment and Other------------------$210.54K$243.95K
BiologicsAndDrugDelivery1Member-------------------$168.25K

ClearPoint Neuro's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Biologics And Drug Delivery (54.33%), Biologics And Drug Delivery - Disposable Products (25.29%), Capital Equipment And Software (10.19%), Capital Equipment And Software - Systems and Software Products (6.77%), and Capital Equipment And Software - Services (3.42%).

ClearPoint Neuro Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
LIVNLivaNova$1.15B$318.11M
SWAVShockWave Medical$730.23M$218.81M
INSPInspire Medical Systems$624.80M$203.19M
NARIInari Medical$493.63M$153.39M
INGNInogen$315.66M$88.83M
KIDSOrthoPediatrics$148.73M$52.80M
SRDXSurmodics$132.58M$30.34M
OMOutset Medical$130.38M$28.67M
SGHTSight Sciences$81.06M$20.16M
LUNGPulmonx$68.67M$20.39M
NPCENeuroPace$65.42M$21.06M
TELATELA Bio$58.45M$18.96M
APYXApyx Medical$52.35M$16.02M
RCELAVITA Medical$50.56M$21.23M
CTSOCytosorbents$36.35M$8.61B
OSAProSomnus$27.65M$7.46M
TBIOTelesis Bio$27.51M$3.44M
CLPTClearPoint Neuro$23.95M$8.12M

CLPT Revenue FAQ

What is ClearPoint Neuro’s yearly revenue?

ClearPoint Neuro's yearly revenue for 2023 was $23.96M, representing an increase of 16.56% compared to 2022. The company's yearly revenue for 2022 was $20.55M, representing an increase of 26.09% compared to 2021. CLPT's yearly revenue for 2021 was $16.3M, representing an increase of 27.05% compared to 2020.

What is ClearPoint Neuro’s quarterly revenue?

ClearPoint Neuro's quarterly revenue for Q3 2024 was $8.12M, a 3.36% increase from the previous quarter (Q2 2024), and a 40.96% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $7.86M, a 2.87% increase from the previous quarter (Q1 2024), and a 32.07% increase year-over-year (Q2 2023). CLPT's quarterly revenue for Q1 2024 was $7.64M, a 12.17% increase from the previous quarter (Q4 2023), and a 40.60% increase year-over-year (Q1 2023).

What is ClearPoint Neuro’s revenue growth rate?

ClearPoint Neuro's revenue growth rate for the last 3 years (2021-2023) was 46.97%, and for the last 5 years (2019-2023) was 113.56%.

What are ClearPoint Neuro’s revenue streams?

ClearPoint Neuro's revenue streams in c 23 are Functional Neurosurgery Navigation and Therapy - Disposable Products, Capital Equipment and Software Revenue, Capital Equipment and Software - Systems and Software Products, Capital Equipment and Software - Services, Biologics and Drug Delivery Revenue, Biologics and Drug Delivery - Disposable Products, Functional Neurosurgery Navigation and Therapy, and Functional Neurosurgery Navigation and Therapy - Services. Functional Neurosurgery Navigation and Therapy - Disposable Products generated $7.59M in revenue, accounting 20.81% of the company's total revenue, up 0.03% year-over-year. Capital Equipment and Software Revenue generated $1.83M in revenue, accounting 5.03% of the company's total revenue, down -20.55% year-over-year. Capital Equipment and Software - Systems and Software Products generated $860K in revenue, accounting 2.36% of the company's total revenue, down -43.12% year-over-year. Capital Equipment and Software - Services generated $973K in revenue, accounting 2.67% of the company's total revenue, up 22.39% year-over-year. Biologics and Drug Delivery Revenue generated $13.6M in revenue, accounting 37.30% of the company's total revenue, up 49.14% year-over-year. Biologics and Drug Delivery - Disposable Products generated $2.15M in revenue, accounting 5.91% of the company's total revenue, down -41.63% year-over-year. Functional Neurosurgery Navigation and Therapy generated $8.52M in revenue, accounting 23.37% of the company's total revenue, down -6.62% year-over-year. Functional Neurosurgery Navigation and Therapy - Services generated $931K in revenue, accounting 2.55% of the company's total revenue, down -39.43% year-over-year.

What is ClearPoint Neuro’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of ClearPoint Neuro was Biologics and Drug Delivery Revenue. This segment made a revenue of $13.6M, representing 37.30% of the company's total revenue.